PAPER Attar A, Bitan G
SEARCH RESULTS
329960 RESULTS
PAPER Anumala UR, Gu J, Lo Monte F, Kramer T, Heyny-von Haussen R, Hölzer J, Goetschy-Meyer V, Schön C, Mall G, Hilger I, Czech C, Herms J, Schmidt B
Fluorescent rhodanine-3-acetic acids visualize neurofibrillary tangles in Alzheimer's disease brains.
Bioorg Med Chem. 2013 Sep 1;21(17):5139-44. PubMed: 23859773PAPER Nutu M, Zetterberg H, Londos E, Minthon L, Nägga K, Blennow K, Hansson O, Ohrfelt A
Evaluation of the Cerebrospinal Fluid Amyloid-β1-42/Amyloid-β1-40 Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders.
Dement Geriatr Cogn Disord. 2013;36(1-2):99-110. PubMed: 23860354PAPER Abraham JD, Promé S, Salvetat N, Rubrecht L, Cobo S, du Paty E, Galéa P, Mathieu-Dupas E, Ranaldi S, Caillava C, Crémer GA, Rieunier F, Robert P, Molina F, Laune D, Checler F, Fareh J
Cerebrospinal Aβ11-x and 17-x levels as indicators of mild cognitive impairment and patients' stratification in Alzheimer's disease.
Transl Psychiatry. 2013 Jul 16;3:e281. PubMed: 23860482PAPER Katsel P, Tan W, Fam P, Purohit DP, Haroutunian V
Cycle checkpoint abnormalities during dementia: a plausible association with the loss of protection against oxidative stress in Alzheimer's disease.
PLoS One. 2013;8(7):e68361. PubMed: 23861893PAPER Birks J, Craig D
Galantamine for vascular cognitive impairment.
Cochrane Database Syst Rev. 2013;4:CD004746. PubMed: 23862185PAPER Kozauer N, Katz R
Regulation of drugs for early Alzheimer's disease.
N Engl J Med. 2013 Jul 18;369(3):288. PubMed: 23863069PAPER Light DW, Darrow J
Regulation of drugs for early Alzheimer's disease.
N Engl J Med. 2013 Jul 18;369(3):288. PubMed: 23863070PAPER Olazarán J, Martínez MD, Rábano A
Normal pressure hydrocephalus mimicking Alzheimer's disease: such an infrequent case?
Clin Neuropathol. 2013 Jul 17; PubMed: 23863346PAPER Wang J, Shan C, Cao W, Zhang C, Teng J, Chen J
SCG10 promotes non-amyloidogenic processing of amyloid precursor protein by facilitating its trafficking to the cell surface.
Hum Mol Genet. 2013 Jul 24; PubMed: 23863461PAPER Maia LF, Kaeser SA, Reichwald J, Hruscha M, Martus P, Staufenbiel M, Jucker M
Changes in amyloid-β and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein.
Sci Transl Med. 2013 Jul 17;5(194):194re2. PubMed: 23863834PAPER Lee C, Park GH, Lee SR, Jang JH
Attenuation of β-amyloid-induced oxidative cell death by sulforaphane via activation of NF-E2-related factor 2.
Oxid Med Cell Longev. 2013;2013:313510. PubMed: 23864927PAPER Belleville S, Bherer L
Biomarkers of Cognitive Training Effects in Aging.
Curr Transl Geriatr Exp Gerontol Rep. 2012 Jun;1(2):104-110. PubMed: 23864998PAPER Hu N, Yu JT, Tan L, Wang YL, Sun L
Nutrition and the risk of Alzheimer's disease.
Biomed Res Int. 2013;2013:524820. PubMed: 23865055PAPER Rama Rao KV, Curtis KM, Johnstone JT, Norenberg MD
Amyloid-β inhibits thrombospondin 1 release from cultured astrocytes: effects on synaptic protein expression.
J Neuropathol Exp Neurol. 2013 Aug;72(8):735-44. PubMed: 23860027Current Filters
No filters selected